ArkeaBio™

📍 Charlestown, United States🗓 Founded 2021👥 39 employees💰 Last funded May 2024
Biotechnology Research🌐 arkeabio.com
Website LinkedIn
ArkeaBio is a global agricultural bioscience company developing a safe, cost-effective vaccine to reduce methane emissions from cattle all over the world. We are the first to successfully demonstrate a proof-of-concept vaccine. It’s the safest, most cost-effective solution for reducing greenhouse gas emissions in agriculture, and it’s the only one that can be quickly and sustainably scaled to reach all the world’s cattle. It’s a singular, scalable solution that delivers value to farmers, brands, consumers and our climate.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Netherlands
1
Frequently asked questions
Who invested in ArkeaBio™?
ArkeaBio™ has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did ArkeaBio™ last raise funding?
The most recent investment in ArkeaBio™ recorded on gritt.io was in May 2024.
When was ArkeaBio™ founded?
ArkeaBio™ was founded in 2021.
What industry is ArkeaBio™ in?
ArkeaBio™ operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ArkeaBio™ based?
ArkeaBio™ is headquartered in Charlestown, United States.